Plan Group Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Sell
6,031
-1,010
-14% -$80.8K 0.09% 140
2025
Q4
$671K Sell
7,041
-1,974
-22% -$194K 0.17% 105
2025
Q3
$880K Buy
9,015
+306
+4% +$31.7K 0.24% 94
2025
Q2
$935K Buy
8,709
+1,234
+17% +$125K 0.31% 83
2025
Q1
$754K Buy
7,475
+3,096
+71% +$312K 0.27% 75
2024
Q4
$391K Buy
4,379
+142
+3% +$12.5K 0.21% 76
2024
Q3
$355K Buy
+4,237
New +$334K 0.19% 79
2023
Q3
Sell
-3,704
Closed -$200K 76
2023
Q2
$200K Buy
+3,704
New +$193K 0.17% 66

Other funds holding BSX

Plan Group Financial's BSX Position: Q1 2026 in Review

Plan Group Financial reduced its Boston Scientific (BSX) stake by 14% in Q1 2026, selling an estimated $80.8K and leaving 6,031 shares worth $378K. The position accounts for 0.09% of the portfolio, ranked #140.

Plan Group Financial first reported a position in BSX in Q2 2023 and has held it in 8 quarters since. The position peaked at $935K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Plan Group Financial held 6,031 shares of Boston Scientific worth $378K as of Q1 2026.
  • Plan Group Financial sold 1,010 Boston Scientific shares in Q1 2026, an estimated $80.8K.
  • Boston Scientific made up 0.09% of Plan Group Financial's portfolio in Q1 2026, its #140 holding.
  • Plan Group Financial first reported a position in Boston Scientific in Q2 2023 and has held it in 8 quarters since.
  • Plan Group Financial's Boston Scientific position peaked at $935K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Plan Group Financial's 13F filing for Q1 2026, filed 13 Apr 2026.